Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Travere Therapeutics Inc.
Goto 0, 1, 2, ...4, 5, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-05-11
Sale
2022-05-12
8:49 pm
Travere Therapeutics Inc. TVTX ROTE WILLIAM E.
VP
1,563 $21.71 $33,940 43,672
(Direct)
View
2022-05-10
Sale
2022-05-12
8:47 pm
Travere Therapeutics Inc. TVTX REED ELIZABETH E
VP
1,950 $21.51 $41,943 41,838
(Direct)
View
2022-05-10
Sale
2022-05-12
8:45 pm
Travere Therapeutics Inc. TVTX Clague Laura
CFO
2,200 $21.51 $47,322 35,655
(Direct)
View
2022-05-10
Sale
2022-05-12
8:44 pm
Travere Therapeutics Inc. TVTX Calvin Sandra
CAO
881 $21.72 $19,134 35,733
(Direct)
View
2022-05-11
Sale
2022-05-12
8:35 pm
Travere Therapeutics Inc. TVTX ASELAGE STEVE
Director
2,575 $21.92 $56,457 146,919
(Direct)
View
2022-02-10
Sale
2022-02-11
4:05 pm
Travere Therapeutics Inc. TVTX Dube Eric M
CEO
4,832 $27.84 $134,523 159,913
(Direct)
View
2022-01-31
Sale
2022-02-02
4:22 pm
Travere Therapeutics Inc. TVTX Calvin Sandra
VP
798 $26.51 $21,152 54,114
(Direct)
View
2022-01-31
Sale
2022-02-02
4:20 pm
Travere Therapeutics Inc. TVTX REED ELIZABETH E
VP
1,350 $27.4 $36,990 100,988
(Direct)
View
2022-01-31
Sale
2022-02-02
4:19 pm
Travere Therapeutics Inc. TVTX ROTE WILLIAM E.
VP
1,125 $27.4 $30,825 102,435
(Direct)
View
2022-01-31
Sale
2022-02-02
4:18 pm
Travere Therapeutics Inc. TVTX Heerma Peter
Chief Commercial Officer
1,125 $27.4 $30,825 124,497
(Direct)
View
2022-01-31
Sale
2022-02-02
4:17 pm
Travere Therapeutics Inc. TVTX Clague Laura
CFO
1,238 $27.4 $33,921 95,055
(Direct)
View
2022-01-31
Sale
2022-02-02
4:16 pm
Travere Therapeutics Inc. TVTX Dube Eric M
CEO
4,813 $27.4 $131,876 372,145
(Direct)
View
2022-01-24
Sale
2022-01-26
4:38 pm
Travere Therapeutics Inc. TVTX Calvin Sandra
VP
934 $24.58 $22,955 28,662
(Direct)
View
2022-01-24
Sale
2022-01-26
4:37 pm
Travere Therapeutics Inc. TVTX ROTE WILLIAM E.
VP
1,875 $24.98 $46,838 36,520
(Direct)
View
2022-01-24
Sale
2022-01-26
4:36 pm
Travere Therapeutics Inc. TVTX Heerma Peter
Chief Commercial Officer
1,875 $24.98 $46,838 58,582
(Direct)
View
2022-01-24
Sale
2022-01-26
4:35 pm
Travere Therapeutics Inc. TVTX REED ELIZABETH E
VP
2,250 $24.98 $56,205 35,298
(Direct)
View
2022-01-24
Sale
2022-01-26
4:34 pm
Travere Therapeutics Inc. TVTX Clague Laura
CFO
2,063 $24.98 $51,534 29,253
(Direct)
View
2022-01-24
Sale
2022-01-26
4:33 pm
Travere Therapeutics Inc. TVTX Dube Eric M
CEO
7,873 $24.98 $196,668 131,710
(Direct)
View
2022-01-10
Sale
2022-01-12
4:07 pm
Travere Therapeutics Inc. TVTX REED ELIZABETH E
VP
5,000 $27.4 $137,000 37,548
(Direct)
View
2022-01-10
Sale
2022-01-12
4:06 pm
Travere Therapeutics Inc. TVTX ROTE WILLIAM E.
VP
2,500 $27.4 $68,500 38,395
(Direct)
View
2022-01-10
Sale
2022-01-12
4:05 pm
Travere Therapeutics Inc. TVTX Clague Laura
CFO
7,500 $27.4 $205,500 31,316
(Direct)
View
2022-01-04
Sale
2022-01-06
4:03 pm
Travere Therapeutics Inc. TVTX Dube Eric M
CEO
17,332 $30.08 $521,407 139,583
(Direct)
View
2021-11-16
Sale
2021-11-18
4:08 pm
Travere Therapeutics Inc. TVTX ASELAGE STEVE
Director
31,800 $29.39 $934,602 149,494
(Direct)
View
2021-11-05
Sale
2021-11-09
4:05 pm
Travere Therapeutics Inc. TVTX ASELAGE STEVE
Director
10,000 $26.23 $262,300 251,294
(Indirect
Direct)
View
2021-11-01
Sale
2021-11-03
4:05 pm
Travere Therapeutics Inc. TVTX ASELAGE STEVE
Director
8,500 $29.69 $252,400 181,294
(Indirect
Direct)
View
2021-10-07
Sale
2021-10-08
4:18 pm
Travere Therapeutics Inc. TVTX ASELAGE STEVE
Director
60,000 $26.25 $1,574,760 269,794
(Direct)
View
2021-10-04
Sale
2021-10-05
4:06 pm
Travere Therapeutics Inc. TVTX Heerma Peter
Chief Commercial Officer
3,058 $24.77 $75,746 60,457
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-05-11
Option Award
2022-05-12
8:42 pm
2023-05-11
2032-05-10
Travere Therapeutics Inc. TVTX Williams Brinkley Ruth
Director
12,000 $0 17,250
(Direct)
View
2022-05-11
Option Award
2022-05-12
8:40 pm
2023-05-11
2032-05-10
Travere Therapeutics Inc. TVTX Squarer Ron
Director
12,000 $0 26,875
(Direct)
View
2022-05-11
Option Award
2022-05-12
8:33 pm
2023-05-11
2032-05-10
Travere Therapeutics Inc. TVTX Poole Sandra
Director
12,000 $0 21,500
(Direct)
View
2022-05-11
Option Award
2022-05-12
8:30 pm
2023-05-11
2032-05-10
Travere Therapeutics Inc. TVTX Orwin John A
Director
12,000 $0 26,875
(Direct)
View
2022-05-11
Option Award
2022-05-12
8:26 pm
2023-05-11
2032-05-10
Travere Therapeutics Inc. TVTX Meckler Jeffrey A
Director
12,000 $0 79,000
(Direct)
View
2022-05-11
Option Award
2022-05-12
8:24 pm
2023-05-11
2032-05-10
Travere Therapeutics Inc. TVTX LYONS GARY A
Director
12,000 $0 49,000
(Direct)
View
2022-05-11
Option Award
2022-05-12
8:22 pm
2023-05-11
2032-05-10
Travere Therapeutics Inc. TVTX COUGHLIN TIMOTHY
Director
12,000 $0 47,000
(Direct)
View
2022-05-11
Option Award
2022-05-12
8:20 pm
2023-05-11
2032-05-10
Travere Therapeutics Inc. TVTX Bruhn Suzanne Louise
Director
12,000 $0 20,250
(Direct)
View
2022-05-11
Option Award
2022-05-12
8:18 pm
2023-05-11
2032-05-10
Travere Therapeutics Inc. TVTX Baynes Roy D.
Director
12,000 $0 29,000
(Direct)
View
2022-01-31
Option Award
2022-02-02
4:22 pm
N/A
2032-01-30
Travere Therapeutics Inc. TVTX Calvin Sandra
VP
26,250 $0 54,114
(Direct)
View
2022-01-31
Option Award
2022-02-02
4:20 pm
N/A
N/A
Travere Therapeutics Inc. TVTX Inrig Jula
Chief Medical Officer
8,000 $0 8,000
(Direct)
View
2022-01-31
Option Award
2022-02-02
4:20 pm
N/A
2032-01-30
Travere Therapeutics Inc. TVTX REED ELIZABETH E
VP
67,040 $0 100,988
(Direct)
View
2022-01-31
Option Award
2022-02-02
4:19 pm
N/A
2032-01-30
Travere Therapeutics Inc. TVTX ROTE WILLIAM E.
VP
67,040 $0 102,435
(Direct)
View
2022-01-31
Option Award
2022-02-02
4:18 pm
N/A
2032-01-30
Travere Therapeutics Inc. TVTX Heerma Peter
Chief Commercial Officer
67,040 $0 124,497
(Direct)
View
2022-01-31
Option Award
2022-02-02
4:17 pm
N/A
2032-01-30
Travere Therapeutics Inc. TVTX Clague Laura
CFO
67,040 $0 95,055
(Direct)
View
2022-01-31
Option Award
2022-02-02
4:16 pm
N/A
2032-01-30
Travere Therapeutics Inc. TVTX Dube Eric M
CEO
245,248 $0 372,145
(Direct)
View
2022-01-10
Option Award
2022-01-12
4:07 pm
N/A
N/A
Travere Therapeutics Inc. TVTX REED ELIZABETH E
VP
5,000 $0 37,548
(Direct)
View
2022-01-10
Option Award
2022-01-12
4:06 pm
N/A
N/A
Travere Therapeutics Inc. TVTX ROTE WILLIAM E.
VP
5,000 $0 38,395
(Direct)
View
2022-01-10
Option Award
2022-01-12
4:05 pm
N/A
N/A
Travere Therapeutics Inc. TVTX Clague Laura
CFO
7,500 $0 31,316
(Direct)
View
2022-01-01
Option Award
2022-01-04
6:09 pm
N/A
2032-12-31
Travere Therapeutics Inc. TVTX Inrig Jula
Chief Medical Officer
100,000 $0 100,000
(Direct)
View
2021-11-05
Exercise
2021-11-09
4:05 pm
N/A
2026-05-18
Travere Therapeutics Inc. TVTX ASELAGE STEVE
Director
10,000 $0 251,294
(Direct)
View
2021-11-05
Exercise
2021-11-09
4:05 pm
N/A
N/A
Travere Therapeutics Inc. TVTX ASELAGE STEVE
Director
10,000 $16.23 251,294
(Direct)
View
2021-11-01
Gift
2021-11-03
4:05 pm
N/A
N/A
Travere Therapeutics Inc. TVTX ASELAGE STEVE
Director
28,000 $0 181,294
(Direct)
View
2021-10-07
Exercise
2021-10-08
4:18 pm
N/A
2026-05-18
Travere Therapeutics Inc. TVTX ASELAGE STEVE
Director
60,000 $0 269,794
(Direct)
View
2021-10-07
Exercise
2021-10-08
4:18 pm
N/A
N/A
Travere Therapeutics Inc. TVTX ASELAGE STEVE
Director
60,000 $16.23 269,794
(Direct)
View
2021-09-15
Ownership
2021-09-23
6:14 pm
N/A
N/A
Travere Therapeutics Inc. TVTX Calvin Sandra
VP
0 $0 136,254
(Direct)
View
Goto 0, 1, 2, ...4, 5, Next